[HTML][HTML] Problems and challenges in the development and validation of human cell-based assays to determine nanoparticle-induced immunomodulatory effects

GJ Oostingh, E Casals, P Italiani, R Colognato… - Particle and fibre …, 2011 - Springer
Background With the increasing use of nanomaterials, the need for methods and assays to
examine their immunosafety is becoming urgent, in particular for nanomaterials that are …

Problems and challenges in the development and validation of human cell-based assays to determine nanoparticle-induced immunomodulatory effects

GJ Oostingh, E Casals, P Italiani… - Particle and Fibre …, 2011 - search.proquest.com
Background: With the increasing use of nanomaterials, the need for methods and assays to
examine their immunosafety is becoming urgent, in particular for nanomaterials that are …

[HTML][HTML] Problems and challenges in the development and validation of human cell-based assays to determine nanoparticle-induced immunomodulatory effects

GJ Oostingh, E Casals, P Italiani… - Particle and Fibre …, 2011 - ncbi.nlm.nih.gov
Background With the increasing use of nanomaterials, the need for methods and assays to
examine their immunosafety is becoming urgent, in particular for nanomaterials that are …

[引用][C] Problems and challenges in the development and validation of human cell-based assays to determine nanoparticle-induced immunomodulatory effects

GJ Oostingh, E Casals, P Italiani, R Colognato… - Particle and Fibre …, 2011 - cir.nii.ac.jp
Problems and challenges in the development and validation of human cell-based assays to
determine nanoparticle-induced immunomodulatory effects | CiNii Research CiNii 国立情報学 …

Problems and challenges in the development and validation of human cell-based assays to determine nanoparticle-induced immunomodulatory effects

GJ Oostingh, E Casals, P Italiani… - Particle and fibre …, 2011 - pubmed.ncbi.nlm.nih.gov
Background With the increasing use of nanomaterials, the need for methods and assays to
examine their immunosafety is becoming urgent, in particular for nanomaterials that are …

Problems and challenges in the development and validation of human cell-based assays to determine nanoparticle-induced immunomodulatory effects

GJ Oostingh, E Casals, P Italiani, R Colognato… - Particle and fibre …, 2011 - ddd.uab.cat
Background: With the increasing use of nanomaterials, the need for methods and assays to
examine their immunosafety is becoming urgent, in particular for nanomaterials that are …

Problems and challenges in the development and validation of human cell-based assays to determine nanoparticle-induced immunomodulatory effects

V Puntes, GJ Oostingh, E Casals… - Particle and Fibre …, 2011 - portalrecerca.uab.cat
Background: With the increasing use of nanomaterials, the need for methods and assays to
examine their immunosafety is becoming urgent, in particular for nanomaterials that are …

Problems and challenges in the development and validation of human cell-based assays to determine nanoparticle-induced immunomodulatory effects.

GJ Oostingh, E Casals, P Italiani… - Particle and Fibre …, 2011 - europepmc.org
Background With the increasing use of nanomaterials, the need for methods and assays to
examine their immunosafety is becoming urgent, in particular for nanomaterials that are …

Problems and challenges in the development and validation of human cell-based assays to determine nanoparticle-induced immunomodulatory effects

GJ Oostingh, E Casals, P Italiani… - Particle and Fibre …, 2011 - go.gale.com
Background With the increasing use of nanomaterials, the need for methods and assays to
examine their immunosafety is becoming urgent, in particular for nanomaterials that are …

[引用][C] Problems and challenges in the development and validation of human cell-based assays to determine nanoparticle-induced immunomodulatory effects

OG JANNEKE, E CASALS, P ITALIANI… - publications.jrc.ec.europa.eu
JRC Publications Repository An official website of the European UnionAn official EU
website How do you know? All official European Union website addresses are in the europa.eu …